GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · BSE Equity Only

BSE Exchange Filings, Explained Simply

AI-powered plain-English analysis of every important BSE announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Today
—
Total
BSE
Exchange
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Strictly sourced from BSE exchange announcements (equity segment only). We show only material, important filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India exchange announcements. More categories will be added over time.
Krsnaa Diagnostics Ltd
Krsnaa Diagnostics Allots 16.21 Lakh Warrants at Rs 566 Each
FUNDRAISE ▲ Positive Development LOW RISK
📅 Filed on BSE: 13 Oct 2026, 07:11 PM IST  ·  BSE ID: 642fcfc1-bdad-4685-8989-020198f9f2d2
View Original BSE Filing (PDF)
💡
In Simple Terms
The company issued special options to its main owners to buy more shares later at a set price, raising some funds now.
🤖 AI Summary
  • Krsnaa Diagnostics allotted 16,21,000 convertible warrants at Rs 566 per warrant.
  • Warrants issued on preferential basis to Promoter and Promoter Group entities.
  • Company received 25% of warrant issue price, aggregating to Rs 22,93,71,500.
  • Warrants convertible into equity shares within 18 months at Rs 566 per share.
🔢 Key Numbers — exact figures from BSE filing, not rounded
Number of Warrants allotted
16,21,000
Warrant Issue Price
₹ 566/-
Total Warrant Subscription Price Received (25%)
₹ 22,93,71,500/-
Equity Share Face Value
₹ 5/-
Equity Share Conversion Price
₹ 566/-
Conversion Period
18 months
🏢 How This Affects the Company
💰
Financial Impact
The company has received an upfront payment of Rs 22,93,71,500 towards the preferential allotment of warrants, strengthening its immediate cash position. The potential future issuance of equity shares upon conversion could dilute existing shareholding but also provide further capital.
👥 What This Means For Shareholders
✅
Action Required
No action is required from shareholders regarding this warrant allotment.
👤
Who Is Affected
Existing shareholders may experience dilution upon future conversion of these warrants into equity shares.
🔍
Management Signal
This decision signals management's intent to secure capital from key stakeholders and maintain alignment with promoter group interests.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
Confirmation of warrant conversion into equity shares.
Updates on the utilization of funds raised from warrant allotment.
Next quarterly results announcement for financial performance updates.
LOW RISK The allotment is to existing promoter entities, and the terms are clearly defined in the filing.
💡 Investor Takeaway
Krsnaa Diagnostics raised Rs 22,93,71,500 by allotting 16,21,000 warrants at Rs 566 each to promoter entities, with conversion possible within 18 months.
⚖️ Strengths & Concerns

✅ Positives

  • Raised Rs 22,93,71,500 upfront from promoter group for warrant allotment.
  • Warrants priced at Rs 566 per warrant, convertible to equity at the same price.
❓ Frequently Asked Questions
How many convertible warrants did Krsnaa Diagnostics allot?
Krsnaa Diagnostics allotted 16,21,000 fully convertible warrants on a preferential basis.
What is the price of each convertible warrant allotted by Krsnaa Diagnostics?
Each warrant was allotted at a price of ₹ 566/-.
How much money did Krsnaa Diagnostics receive upfront for these warrants?
The company received 25% of the warrant issue price, aggregating to ₹ 22,93,71,500/-.
Who received the convertible warrants allotted by Krsnaa Diagnostics?
The warrants were allotted to Mr. Rajendra Mutha (Promoter) and Krsna Diagnostics (Mumbai) Private Limited (Promoter Group entity).
What is the timeframe for converting these warrants into equity shares?
The warrants are convertible into equity shares within a maximum period of 18 months from the allotment date of October 13, 2026.

Questions based on this BSE filing only. For information purposes.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.